Pluristem Therapeutics, Inc., an Israeli based company developing placenta-based cell therapies, and New York University (NYU) Medical Center today announced the formation of a partnership to study the use of Pluristem’s proprietary placenta-derived PLX cells for the treatment of diabetic foot ulcers… Read more
Harvard University and Hebrew University scientists have developed a low cost, nanometer-sized drug to treat chronic wounds, such as diabetic foot ulcers or burns.
Several proteins, called growth factors, have been found to speed up the healing process, however purifying these growth factor proteins is very expensive, and they do not last long on the injured site…. Read more
Dermagraft is an advanced wound care product that contains living human skin cells… Read more
Now science may have found a way of mobilizing stem cells within the body to treat this health issue, which affects more than three million Americans annually.
Recent studies have shown that surgically moving mesenchymal stem cells (MSCs)… Read more